Evidence map›Paper›PMID 26557043›Full record

ArticleCentral-European journal of immunology2015

Asplenia in children with congenital heart disease as a cause of poor outcome.

Semiha Bahceci Erdem, Ferah Genel, Baris Erdur, Erhan Ozbek, Nesrin Gulez, Timur Mese

Open access · goldAbstract readCase Reports
In one paragraph

Article in Central-European journal of immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Semiha Bahceci ErdemDepartment of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Ferah GenelDepartment of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Baris ErdurDepartment of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Erhan OzbekDepartment of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Nesrin GulezDepartment of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Timur MeseDepartment of Pediatric Cardiology, Dr. Behcet Uz Children Training and Research Hospital, İzmir, Turkey.
Dr. Behçet Uz Çocuk Hastalıkları Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absence of a spleen is a well-known risk factor for severe bacterial infections, especially due to encapsulated bacteria. Congenital asplenia can be part of multiple congenital abnormalities as in heterotaxy including Ivemark syndrome with congenital anomalies of the heart or great vessels, or it can be isolated, which is extremely rare. In these cases, asplenia is an important factor effecting mortality. In this report, the clinical courses of five children with asplenia and concomitant minor or complex cardiac anomalies are presented. The ages of the children ranged between 1.5 and 17 months at the time of diagnosis. All of the cases had had a history of hospitalisation for infectious diseases before the diagnosis. The patient who was diagnosed at 17 months old had a history pneumonia, urinary tract infection, and bacterial meningitis beginning at five months old. Three children had complex cardiac anomalies, one child had ventricular septal defect, and one child had atrial septal defect. Howell-Jolly bodies were determined in peripheral blood smear in all of the patients. The diagnoses of asplenia were confirmed with spleen scintigraphy. One of the patients with complex cardiac anomalies died a short time after diagnosis, because of cardiac failure. The rest of the four patients were vaccinated for encapsulated bacteria and were taken under antibiotic prophylaxis. These children did not need hospitalisation for infectious diseases during the follow-up period (5-40 months). In asplenic children, early diagnosis, antibiotic prophylaxis, and immunisation for encapsulated bacteria can decrease the risk of morbidity and mortality.

Indexed as

aspleniacardiac anomalieschildheterotaxy syndromeimmunisationinfection

Identifiers

PMID26557043
PMCPMC4637402
OpenAlexW2411197225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.